-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Ganoderma has been proven to have weight loss effects.
Studies have found that BSGLP can inhibit obesity, hyperlipidemia, inflammation and fat accumulation in C57BL/6J mice induced by high-fat diet (HFD).
Mechanisms of BSGLP inhibiting obesity and inflammation induced by high-fat diet
Mechanisms of BSGLP inhibiting obesity and inflammation induced by high-fat dietIn summary, this study shows for the first time that BSGLP may be used as a probiotic for inhibiting obesity and hyperlipidemia by regulating inflammation, intestinal microflora and intestinal barrier function .
BSGLP BSGLP may be used as a probiotic to inhibit obesity and hyperlipidemia by regulating inflammation, intestinal microflora and intestinal barrier function, and may be used as a probiotic by regulating inflammation, intestinal microflora and intestinal barrier function.
Suppression of obesity and inflammation by polysaccharide from sporoderm-broken spore of Ganoderma lucidum via gut microbiota regulation in this message